As of June 10, 2025, NU Skin Enterprises Inc's estimated intrinsic value ranges from $23.84 to $23.84 per share, depending on the valuation methodology applied.
Valuation Method | Fair Value (USD) | Implied Upside/Downside |
---|---|---|
Earnings Power Value | $23.84 | +196.5% |
Is NU Skin Enterprises Inc (NUS) undervalued or overvalued?
With the current market price at $8.04, the stock appears to be significantly undervalued.
Intrinsic value represents the "true" worth of a company based on its fundamentals rather than market sentiment. We've employed multiple methodologies to triangulate NU Skin Enterprises Inc's intrinsic value, including:
The cost of capital is a critical factor in valuation models, representing the required return for investors.
WACC Component | Low | High |
---|---|---|
Long-term bond rate | 3.9% | 4.4% |
Equity market risk premium | 4.6% | 5.6% |
Adjusted beta | 0.34 | 0.55 |
Cost of equity | 5.4% | 8.0% |
Cost of debt | 5.3% | 20.9% |
Tax rate | 22.3% | 29.9% |
Debt/Equity ratio | 1.03 | 1.03 |
After-tax WACC | 4.8% | 11.3% |
EPV assesses a company's value based on its current normalized earnings power, assuming no growth.
EPV Component | Value |
---|---|
Normalized Earnings | $82M |
Discount Rate (WACC) | 11.3% - 4.8% |
Enterprise Value | $719M - $1,707M |
Net Debt | $35M |
Equity Value | $684M - $1,672M |
Outstanding Shares | 49M |
Fair Value | $14 - $34 |
Selected Fair Value | $23.84 |
Metric | Value |
---|---|
Market Capitalization | $397M |
Enterprise Value | $432M |
Trailing P/E | 0.00 |
Forward P/E | 0.00 |
Trailing EV/EBITDA | 5.10 |
Current Dividend Yield | 304.99% |
Dividend Growth Rate (5Y) | -37.55% |
Debt-to-Equity Ratio | 1.03 |
To determine the most reliable intrinsic value estimate, we weigh each valuation method based on:
Valuation Method | Weight | Weighted Value |
---|---|---|
Earnings Power Value | 100% | $2.38 |
Weighted Average | 100% | $23.84 |
Based on our comprehensive valuation analysis, NU Skin Enterprises Inc's weighted average intrinsic value is $23.84, which is approximately 196.5% above the current market price of $8.04.
Key investment considerations:
Given these factors, we believe NU Skin Enterprises Inc is currently significantly undervalued with the potential for long-term appreciation based on the company's growth trajectory and financial strength.